145 related articles for article (PubMed ID: 11289568)
1. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study.
Klotz T; Sachse R; Heidrich A; Jockenhövel F; Rohde G; Wensing G; Horstmann R; Engelmann R
World J Urol; 2001 Feb; 19(1):32-9. PubMed ID: 11289568
[TBL] [Abstract][Full Text] [Related]
2. Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study.
Rosenberg MT; Adams PL; McBride TA; Roberts JN; McCallum SW
Int J Clin Pract; 2009 Jan; 63(1):27-34. PubMed ID: 19125990
[TBL] [Abstract][Full Text] [Related]
3. Duration of erection: does it really matter? A randomized, double-blind clinical trial to assess the impact of vardenafil ODT on duration of erection and its correlation with patients' and partners' sexual quality of life and duration of intercourse: the VADEOPEN study.
Martin-Morales A; Gutiérrez-Hernández P; Romero-Otero J; Romero-Martín JA;
J Sex Med; 2014 Jun; 11(6):1527-38. PubMed ID: 24628736
[TBL] [Abstract][Full Text] [Related]
4. Vardenafil improves penile erection in type 2 diabetes mellitus patients with erectile dysfunction: role of tropomyosin.
Zamorano-León JJ; Olivier C; de Las Heras N; Mateos-Cáceres PJ; Brime Menéndez R; Rodríguez-Sierra P; Martín Palacios N; Manso LS; Modrego J; Segura A; Macaya C; López-Farré AJ
J Sex Med; 2013 Dec; 10(12):3110-20. PubMed ID: 24112450
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of vardenafil in East Asian men with erectile dysfunction.
Chen KK; Paick JS; Ishii N; On Behalf Of The Vardenafil Study Group
J Sex Med; 2007 May; 4(3):753-761. PubMed ID: 17498108
[TBL] [Abstract][Full Text] [Related]
6. Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury.
Giuliano F; Rubio-Aurioles E; Kennelly M; Montorsi F; Kim ED; Finkbeiner AE; Pommerville PJ; Colopy MW; Wachs BH;
Spine (Phila Pa 1976); 2008 Apr; 33(7):709-15. PubMed ID: 18379396
[TBL] [Abstract][Full Text] [Related]
7. Is vardenafil "noninferior" or superior to sildenafil in the management of erectile dysfunction? Revisiting the biochemical, physiological, and clinical evidence.
Traish A; Kim N
J Sex Med; 2008 Jul; 5(7):1762-8; discussion 1768-9. PubMed ID: 18221281
[No Abstract] [Full Text] [Related]
8. Vardenafil allows successful intercourse initiated rapidly after dosing in Japanese patients with diabetes mellitus and erectile dysfunction.
Nagao K; Kobayashi H; Fujikawa K; Tachibana T; Iwamoto Y; Ishii N; Turek PJ; Brant WO; Kamidono S
J Sex Med; 2009 Oct; 6(10):2851-7. PubMed ID: 19732311
[TBL] [Abstract][Full Text] [Related]
9. Vardenafil in the treatment of erectile dysfunction in outpatients with chronic schizophrenia: a flexible-dose, open-label study.
Mitsonis CI; Mitropoulos PA; Dimopoulos NP; Kararizou EG; Psarra VV; Tsakiris FE; Katsanou MN
J Clin Psychiatry; 2008 Feb; 69(2):206-12. PubMed ID: 18348599
[TBL] [Abstract][Full Text] [Related]
10. The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
Sperling H; Debruyne F; Boermans A; Beneke M; Ulbrich E; Ewald S
J Sex Med; 2010 Apr; 7(4 Pt 1):1497-507. PubMed ID: 20233275
[TBL] [Abstract][Full Text] [Related]
11. Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile Function in patients treated with a phosphodiesterase type 5 inhibitor.
Shaw JW; Reardon G; Sandor DW; Rosen RC; Ferguson DM
J Sex Med; 2010 Mar; 7(3):1147-59. PubMed ID: 20113397
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.
Mathers MJ; Klotz T; Brandt AS; Roth S; Sommer F
BJU Int; 2008 May; 101(9):1129-34. PubMed ID: 18190629
[TBL] [Abstract][Full Text] [Related]
13. Vardenafil: a selective inhibitor of phosphodiesterase-5 for the treatment of erectile dysfunction.
Reffelmann T; Kloner RA
Expert Opin Pharmacother; 2007 May; 8(7):965-74. PubMed ID: 17472542
[TBL] [Abstract][Full Text] [Related]
14. Vardenafil in men with stable statin therapy and dyslipidemia.
Miner M; Gilderman L; Bailen J; Cook D; Dawson K; Stanislaus M; Beresford E; Barnes A
J Sex Med; 2008 Jun; 5(6):1455-67. PubMed ID: 18373526
[TBL] [Abstract][Full Text] [Related]
15. Vardenafil: efficacy, tolerability and future directions.
Rice KR; Dean RC
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):553-62. PubMed ID: 19416089
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic efficacy of a course administration of vardenafil--inhibitor of phosphodiesterase-5--in erectile dysfunction].
Aliaev IuG; Vinarov AZ; Akhvlediani ND
Urologiia; 2007; (1):45-6, 49. PubMed ID: 17471999
[TBL] [Abstract][Full Text] [Related]
17. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.
Gökçe A; Halis F; Demirtas A; Ekmekcioglu O
BJU Int; 2011 Apr; 107(8):1274-7. PubMed ID: 21929518
[TBL] [Abstract][Full Text] [Related]
18. Erectile dysfunction: management update.
Fazio L; Brock G
CMAJ; 2004 Apr; 170(9):1429-37. PubMed ID: 15111479
[TBL] [Abstract][Full Text] [Related]
19. [Vardenafil for refractory erectile dysfunction: the latest advances].
Wang HY; Huang YF
Zhonghua Nan Ke Xue; 2009 Nov; 15(11):1035-8. PubMed ID: 20218319
[TBL] [Abstract][Full Text] [Related]
20. The real-life safety and efficacy of vardenafil: an international post-marketing surveillance study of 2824 patients from the Middle East.
Kamel A; Khaouli R; Sabha M; Al Mitwally K; Fouad W; Landen H
Clin Drug Investig; 2007; 27(5):339-46. PubMed ID: 17451282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
